PRPO
Precipio Inc
23.10$
-0.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.0% | -8.2% | +4.2% | -2.1% | +0.3% | +4.6% | +5.8% | +12.4% | +0.8% | -2.4% | +2.5% | |
| – | -14.6% | -29.5% | +29.6% | -3.2% | +6.0% | -5.0% | +23.6% | +39.8% | +6.5% | -1.8% | +10.2% | |
| – | -3.8% | -48.3% | +64.8% | -17.7% | +31.9% | -26.8% | +11.1% | +104.0% | +162.0% | -56.9% | +18.1% | |
| – | -3.8% | -48.3% | +64.8% | -17.7% | +31.9% | -26.8% | +11.1% | +104.0% | +162.0% | -56.9% | +18.1% | |
| – | -12.3% | -30.4% | +22.2% | -7.8% | -21.7% | +22.2% | +52.5% | +31.5% | +1.4% | +0.2% | +14.6% | |
| – | -39.6% | +38.5% | +22.7% | -9.6% | +22.7% | +14.0% | +28.4% | -25.6% | +18.7% | -7.0% | -10.8% | |
| – | -1.8% | -1.8% | -1.9% | -1.9% | -2.0% | -2.0% | -2.0% | -2.1% | -2.1% | -2.2% | -2.2% | |
| – | -39.3% | +4.8% | +35.1% | -3.8% | -2.1% | +24.2% | +7.2% | +13.4% | -8.8% | -1.8% | -1.1% | |
| – | -42.4% | +5.9% | +38.1% | -2.5% | -4.6% | +1.4% | +0.5% | +2.3% | -15.7% | +1.5% | -2.9% | |
| – | -45.0% | -29.9% | +113.4% | -14.1% | -17.3% | -23.3% | -8.6% | +40.1% | +6.2% | +2.6% | +9.0% | |
| – | -75.2% | +45.5% | -5.5% | -18.0% | -11.8% | +46.6% | +28.5% | -2.2% | -0.6% | +20.5% | -28.7% | |
| – | -6.2% | -6.6% | -7.1% | -8.7% | -8.3% | -9.1% | -11.4% | -11.3% | -14.5% | -14.9% | +530.0% | |
| – | +11.5% | -11.5% | -5.2% | -1.4% | +1.2% | -3.3% | +5.0% | +11.9% | +5.9% | -2.7% | +4.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.8% | +0.4% | +2.6% | +1.1% | +0.9% | +0.6% | +6.6% | +2.2% | -2.0% | +11.1% | +0.2% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.